Free Trial

SPDR S&P Biotech ETF Rating

SPDR S&P Biotech ETF logo
$89.85 -0.44 (-0.49%)
Closing price 08/29/2025 04:10 PM Eastern
Extended Trading
$89.89 +0.04 (+0.04%)
As of 08/29/2025 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

XBI Aggregate Rating

Moderate Buy
2.71

Holdings in XBI have an aggregate rating of Moderate Buy based on 486 analyst ratings issued in the past year covering 25 companies (57.1% of the portfolio).

XBI Aggregate Price Target

$89.85
High Prediction$89.85
Average Prediction$89.85
Low Prediction$89.85

Holdings in XBI have an aggregate price target of $89.85 and a range of $89.85 to $89.85 covering 25 companies (57.1% of the portfolio).

XBI Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
Moderate Buy
14 Moderate Buy rating(s)
Hold
6 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by SPDR S&P Biotech ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 25 XBI Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
3.61%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$446.51
-1.3%
4.0033 of 5 stars
2.85$405.33 -9.2%26News Coverage
Positive News
3.06%
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$73.15
+0.5%
4.6505 of 5 stars
2.18$67.11 -8.3%11News Coverage
Positive News
3.06%
Insmed, Inc. stock logo
INSM
Insmed
$136.10
+0.8%
3.7615 of 5 stars
2.94$132.57 -2.6%17Positive News
2.92%
Incyte Corporation stock logo
INCY
Incyte
$84.61
+1.1%
4.6248 of 5 stars
2.33$81.60 -3.6%18News Coverage
Positive News
2.67%
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$304.76
-0.8%
4.9812 of 5 stars
2.69$382.00 25.3%13Positive News
2.60%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$580.70
+0.2%
4.7838 of 5 stars
2.81$817.67 40.8%27Trending News
Analyst Forecast
2.54%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$112.97
+0.4%
4.9684 of 5 stars
2.88$115.39 2.1%26Positive News
Insider Trade
2.53%
AbbVie Inc. stock logo
ABBV
AbbVie
$210.25
+1.1%
4.7107 of 5 stars
2.92$214.95 2.2%26Trending News
2.52%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$139.60
+0.5%
4.9578 of 5 stars
2.86$159.50 14.3%21News Coverage
Positive News
2.46%
Biogen Inc. stock logo
BIIB
Biogen
$132.22
-0.3%
4.8614 of 5 stars
2.34$185.74 40.5%32Positive News
2.38%
Amgen Inc. stock logo
AMGN
Amgen
$287.71
+0.7%
4.5668 of 5 stars
2.33$304.43 5.8%21Trending News
Analyst Revision
2.37%
Moderna, Inc. stock logo
MRNA
Moderna
$24.09
-1.6%
4.514 of 5 stars
2.04$42.88 78.0%24
2.36%
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$51.76
-1.5%
4.2489 of 5 stars
3.00$62.18 20.1%17News Coverage
Positive News
Analyst Forecast
2.36%
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$58.27
+1.0%
4.9947 of 5 stars
2.72$93.17 59.9%25News Coverage
Positive News
2.28%
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$437.85
+0.2%
3.8308 of 5 stars
2.90$459.25 4.9%10Positive News
Analyst Forecast
2.26%
Natera, Inc. stock logo
NTRA
Natera
$168.25
+0.2%
3.0395 of 5 stars
3.06$193.19 14.8%18Positive News
2.13%
Exelixis, Inc. stock logo
EXEL
Exelixis
$37.42
-1.3%
4.8418 of 5 stars
2.52$44.06 17.7%23Trending News
Analyst Downgrade
Analyst Revision
2.03%
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$391.02
-0.3%
4.9397 of 5 stars
2.56$497.10 27.1%27Positive News
1.93%
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
$47.42
+1.0%
4.9322 of 5 stars
2.91$67.05 41.4%23
1.70%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.93
-0.1%
3.1796 of 5 stars
3.25$16.50 38.3%4News Coverage
Positive News
1.57%
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$35.33
-5.4%
3.6688 of 5 stars
2.93$71.58 102.6%15News Coverage
Positive News
High Trading Volume
1.52%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$51.83
-2.3%
3.5942 of 5 stars
2.47$71.60 38.1%17Positive News
Analyst Upgrade
Analyst Revision
1.51%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$42.63
+0.0%
4.4879 of 5 stars
2.86$59.64 39.9%14News Coverage
Options Volume
1.37%
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$37.97
-0.9%
4.3506 of 5 stars
3.00$69.92 84.2%13News Coverage
Positive News
1.37%
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
$46.58
-4.1%
3.0842 of 5 stars
3.06$67.00 43.8%18Positive News
Insider Trade

This page (NYSEARCA:XBI) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners